Regeneron Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hi, everybody. It's Alethia Young here. I cover large cap, small mid cap biotech at Cantor. Obviously, this company needs no introduction, but Regeneron. We're actually going to be having a very specific conversation with Regeneron today around their Regeneron Genetics Medicines. I'm very happy to have the RGC leader, Dr. Aris Baras. He's SVP, General Manager at Regeneron Genetic Center and, of course we don't -- Justin doesn't need an introduction, with Justin Holko, he is VP of IR at Regeneron.
So we are going to do a fireside chat and we'll just dive right in, so --
Alethia, maybe before we jump in, if I could just give the quick forward-looking statement. And then I think Aris has a couple of points, he'd probably like to jump in with.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
